Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ArQule Inc (NASDAQ:ARQL)

1.64
Delayed Data
As of Feb 05
 -0.05 / -2.96%
Today’s Change
1.09
Today|||52-Week Range
2.65
-24.42%
Year-to-Date
No recent news for ArQule Inc.

Today’s Trading

Previous close1.69
Today’s open1.69
Day’s range1.62 - 1.69
Volume94,373
Average volume (3 months)135,549
Market cap$103.1M
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+5.13%
Earnings growth (this year)+37.84%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-29.28%
P/E ratioNM
Price/Sales6.79
Price/Book2.54

Competitors

 Today’s
change
Today’s
% change
MRNSMarinus Pharmaceutic...-0.31-5.51%
ATHXAthersys Inc-0.01-0.81%
SYNSynthetic Biologics ...-0.07-5.74%
XOMAXOMA Corp-0.06-6.63%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$11.3M
Annual profit (last year)-$23.4M
Net profit margin-207.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President &
Chief Operating Officer
Peter S. Lawrence
Corporate headquarters
Woburn, Massachusetts

Forecasts

Partner Offers